Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
2 trials
Recent
Start date
Enrollment
Carcinoma, Renal Cell
×
belzutifan
×
30 days
×
Clear all
Filters
3
NCT07227402
2026-03-16
LITESPARK-033
Merck Sharp & Dohme LLC
Phase 3
Recruiting
904 enrolled
NCT07049926
2026-02-19
MK-3475-03C
Merck Sharp & Dohme LLC
Phase 1/2
Recruiting
140 enrolled